140 related articles for article (PubMed ID: 10638988)
1. Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer.
Olapade-Olaopa EO; Moscatello DK; MacKay EH; Horsburgh T; Sandhu DP; Terry TR; Wong AJ; Habib FK
Br J Cancer; 2000 Jan; 82(1):186-94. PubMed ID: 10638988
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer.
Olapade-Olaopa EO; Moscatello DK; MacKay EH; Sandhu DP; Terry TR; Wong AJ; Habib FK
Afr J Med Med Sci; 2004 Sep; 33(3):245-53. PubMed ID: 15819472
[TBL] [Abstract][Full Text] [Related]
3. Expression of Epidermal Growth Factor Receptor variant III in laryngeal carcinoma tissues.
Yang B; Chen J; Zhang X; Cao J
Auris Nasus Larynx; 2009 Dec; 36(6):682-7. PubMed ID: 19427146
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III.
Zeineldin R; Rosenberg M; Ortega D; Buhr C; Chavez MG; Stack MS; Kusewitt DF; Hudson LG
Mol Carcinog; 2006 Nov; 45(11):851-60. PubMed ID: 16788982
[TBL] [Abstract][Full Text] [Related]
5. Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors.
Steffensen KD; Waldstrøm M; Olsen DA; Corydon T; Lorentzen KA; Knudsen HJ; Jeppesen U; Brandslund I; Jakobsen A
Clin Cancer Res; 2008 Jun; 14(11):3278-82. PubMed ID: 18519753
[TBL] [Abstract][Full Text] [Related]
6. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
Theodoropoulou M; Arzberger T; Gruebler Y; Jaffrain-Rea ML; Schlegel J; Schaaf L; Petrangeli E; Losa M; Stalla GK; Pagotto U
J Endocrinol; 2004 Nov; 183(2):385-94. PubMed ID: 15531726
[TBL] [Abstract][Full Text] [Related]
7. Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.
Blehm KN; Spiess PE; Bondaruk JE; Dujka ME; Villares GJ; Zhao YJ; Bogler O; Aldape KD; Grossman HB; Adam L; McConkey DJ; Czerniak BA; Dinney CP; Bar-Eli M
Clin Cancer Res; 2006 Aug; 12(15):4671-7. PubMed ID: 16899617
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
[TBL] [Abstract][Full Text] [Related]
11. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression.
Hobisch A; Fiechtl M; Sandahl-Sorensen B; Godoy-Tundidor S; Artner-Dworzak E; Ramoner R; Bartsch G; Culig Z
Prostate; 2004 Jun; 59(4):401-8. PubMed ID: 15065088
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity.
Lammering G; Hewit TH; Holmes M; Valerie K; Hawkins W; Lin PS; Mikkelsen RB; Schmidt-Ullrich RK
Clin Cancer Res; 2004 Oct; 10(19):6732-43. PubMed ID: 15475464
[TBL] [Abstract][Full Text] [Related]
15. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.
Yeh TS; Tseng JH; Liu NJ; Chen TC; Jan YY; Chen MF
Arch Surg; 2005 Dec; 140(12):1184-90. PubMed ID: 16365240
[TBL] [Abstract][Full Text] [Related]
16. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor, nuclear proliferation antigen and interleukin-2 receptor expression in prostatic cancer.
Lloyd SN; McClinton S; Brown IL; Miller ID; Kirk D; Eremin O; Moffat LE; Leake RE
J Clin Lab Immunol; 1990 Jun; 32(2):55-8. PubMed ID: 1967039
[TBL] [Abstract][Full Text] [Related]
19. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer.
Winter RN; Kramer A; Borkowski A; Kyprianou N
Cancer Res; 2001 Feb; 61(3):1227-32. PubMed ID: 11221855
[TBL] [Abstract][Full Text] [Related]
20. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.
Mukherjee J; DeSouza LV; Micallef J; Karim Z; Croul S; Siu KW; Guha A
Cancer Res; 2009 Nov; 69(22):8545-54. PubMed ID: 19903856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
